Sigma Healthcare (ASX:SIG) decided to withdraw its interest from and halt discussions regarding the acquisition of UK drugstore chain Boots Group, according to a Monday filing with the Australian bourse.
Following a preliminary review, the company concluded that the acquisition would not currently meet its strategic and capital investment objectives in advancing its UK expansion, the filing said.